360 results on '"Lindholt, J."'
Search Results
2. PB0595 The Profile of Contact Activation System Proteins in Human Abdominal Aortic Aneurysm Plasma-and Tissue Samples
3. Editor's Choice – Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS)
4. Editor's Choice – Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
5. The effect of vitamin K2 supplementation on coronary artery disease in a randomized multicenter trial
6. A Multicentre Observational Study of the Outcomes of Screening Detected Sub-aneurysmal Aortic Dilatation
7. Population Screening and Intervention for Vascular Disease in Danish Men (VIVA): A Randomised Controlled Trial
8. Prevalence of ascending thoracic aortic dilatations based upon absolute and individual predicted normal aortic size measured by CT and echocardiography. A substudy from the DANCAVAS trial: 382
9. Association of ficolin‐3 with abdominal aortic aneurysm presence and progression
10. Baseline prevalence of abdominal aortic aneurysm, peripheral arterial disease and hypertension in men aged 65–74 years from a population screening study (VIVA trial)
11. Corrigendum to ‘Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections’ [European Journal of Vascular & Endovascular Surgery 59/3 (2020) 339–384] (European Journal of Vascular & Endovascular Surgery (2020) 59(3) (339–384), (S1078588419325328), (10.1016/j.ejvs.2019.10.016))
12. Statin use and rupture of abdominal aortic aneurysm
13. Authorsʼ reply: Lack of association between inguinal hernia and abdominal aortic aneurysm in a population-based male cohort (Br J Surg 2013; 100: 1478–1482)
14. Lack of association between inguinal hernia and abdominal aortic aneurysm in a population-based male cohort
15. Upper limb arterial thromboembolism: a systematic review on incidence, risk factors, and prognosis, including a meta-analysis of risk-modifying drugs
16. Atrial fibrillation and upper limb thromboembolectomy: a national cohort study
17. Meta-analysis of postoperative mortality after elective repair of abdominal aortic aneurysms detected by screening
18. Corrigendum to ‘Management of Chronic Venous Disease: Clinical Practice Guidelines’ [European Journal of Vascular & Endovascular Surgery 49/6 (2015) 678/737]
19. Randomized double-blind placebo-controlled crossover study of caffeine in patients with intermittent claudication
20. Long-term benefit and cost-effectiveness analysis of screening for abdominal aortic aneurysms from a randomized controlled trial
21. Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis
22. Risk of arterial calcification by conventional vitamin K antagonist treatment
23. Serum-elastin-peptides as Clinical Predictors of the Natural History of Abdominal Aortic Aneurysms
24. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion (Br J Surg 2001; 88: 1066-72): Authors' reply
25. Management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the European Society for Vascular Surgery (ESVS)
26. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms
27. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion
28. Screening for abdominal aortic aneurysm
29. Apolipoprotein E genotype is associated with differential expansion rates of small abdominal aortic aneurysms
30. Relationship between abdominal aortic aneurysm compliance and serum markers of elastin and collagen metabolism
31. Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of small abdominal aortic aneurysms and declining ankle blood pressure
32. Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm
33. New vascular guidelines for treating acute and chronic limb-threatening ischaemia
34. Adherence to prescribed drugs among 65-74 years old men diagnosed with abdominal aortic aneurysm or peripheral arterial disease in a randomized screening trial. A VIVA substudy
35. Aortic valve calcification in a general population
36. Leukotriene B4 plasma levels are associated to abdominal aortic aneruysm prevalence and progression
37. Major Amputation Rates in Patients with Peripheral Arterial Disease Aged 50 Years and Over in Denmark during the period 1997–2014 and their Relationship with Demographics, Risk Factors, and Vascular Services
38. 456Risk of arterial calcification by conventional vitamin K antagonist treatment
39. Prevalence Of Peripheral Arterial Disease, Hypertension And Diabetes In A Population Of 66-82 Years Old Asymptomatic Women 6 Years After Screening-Detected Carotid Plaque
40. Baseline findings of the population-based, randomized, multifaceted Danish cardiovascular screening trial (DANCAVAS) of men aged 65–74 years
41. Mass or High-Risk Screening for Abdominal Aortic Aneurysm
42. Management of Descending Thoracic Aorta Diseases: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
43. P4.01: Plasma Fibulin-1 is Increased in Patients with Abdominal Aortic Aneurysm But Not Peripheral Atherosclerotic Disease
44. P6256Adherence to prescribed drugs among 65-74 years old men diagnosed with abdominal aortic aneurysm or peripheral arterial disease in a randomized screening trial. A VIVA substudy
45. P6482Measurement of left atrial size by non-contrast computed tomography, 2D and 3D transthoracic echocardiography compared to cardiac magnetic resonance imaging
46. P6055Aortic valve calcification in a general population
47. P4447Association of left atrial size by non-contrast computed tomography with cardiovascular risk factors - the danish cardiovascular screening trial (DANCAVAS)
48. Cost-effectiveness of population-based vascular disease screening and intervention in men from the Viborg Vascular (VIVA) trial
49. P365Leukotriene B4 plasma levels are associated to abdominal aortic aneruysm prevalence and progression
50. Editor's Choice – Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.